Newer types are known as 'atypical' and have been used since the 1970s.
They are used when other treatments for schizophrenia have failed. They target a range of neurotransmitters, e.g. dopamine, serotonin and glutamate.
Common examples are clozapine, risperidone.
Clozapine is thought to improve mood, reduce anxiety, and depression and can be used if thought a person is a high risk for suicide. Risperidone was developed in the 1990s, and is thought to be safer than clozapine and requires lower dosage due to binding strongly to dopamine receptors